Soft M&A Market in H1 2014 as Number of Deals in Omics/MDx Space Drops 33 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Mergers and acquisitions in the omics and molecular diagnostics space stayed soft through the first half of the year as the number of deals dropped 33 percent year over year.

Through the six months ending June 30, 16 M&A deals were either announced or completed, down from 24 in the first half of 2013. Sequentially, the drop was 30 percent from 23 deals in the second half of 2013.

The numbers include those transactions in which an entire company was acquired, but does not include the purchases of assets or divisions only.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.